Jörg Walden, MD
- 7Articles
- 20.9KReads
- 1999–2005Active
- 29Collaborators
About
Jörg Walden, MD, has published extensively on the treatment and clinical characteristics of bipolar disorder and major depressive disorder between 1999 and 2005. His work includes investigations into adjunctive pharmacological therapies such as zonisamide, levetiracetam, lamotrigine, and tiagabine for mood disorders, as well as studies on factors related to suicide attempts and weight issues in bipolar patients. Walden’s research also spans neurology and the evaluation of treatment efficacy in acute mania.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
